vancomycin has been researched along with Disbacteriosis in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (47.83) | 24.3611 |
| 2020's | 12 (52.17) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, S; Huang, C; Huo, F; Liu, H | 1 |
| Ariki, S; Chalalai, T; Dewayani, A; Fujitsuka, N; Fukuda, C; Hidano, S; Ishizawa, S; Ito, K; Kamiyama, N; Kobayashi, T; Kubota, K; Kudo, Y; Minata, M; Mizukami, K; Mogami, S; Murakami, K; Nishiyama, M; Ozaka, S; Ozaki, T; Sachi, N; Soga, Y; Sonoda, A | 1 |
| Baker, PJ; Belkaid, Y; Brenchley, JM; Fennessey, CM; Flynn, JK; Keele, BF; Langner, CA; Ortiz, AM; Simpson, J; Stacy, A; Starke, CE; Vinton, CL | 1 |
| Barrios, BE; Floyd, AN; Gaddipati, S; John, V; Joyce, EL; Kaye, ME; Kulkarni, DH; McDonald, KG; Newberry, RD; Pauta, JT; Rusconi, B; Schill, EM; Udayan, S | 1 |
| Brancaglion, GA; Corsetti, PP; Cristina de Melo Santos, N; de Almeida, LA; Novaes, RD; Pereira, JA; Rosa, CP; Silva, EN; Tagliati, CA | 1 |
| Abokor, AA; Golonka, RM; Heikenwalder, M; Joe, B; Patterson, AD; Singh, V; Tian, Y; Vijay-Kumar, M; Yeoh, BS | 1 |
| Cheng, G; Cheng, L; Kong, L; Li, M; Ma, Y; Peng, X; Qiu, W; Ren, B; Wu, H; Zhou, X | 1 |
| Das, R; Lin, H; Liu, L; Luo, Y; Mao, D; Qi, H; Shi, J; Wang, Q; Wang, S; Wu, X; Xue, Y; Yang, J | 1 |
| Bauduin, M; Beury, D; Dessein, R; Faure, K; Faveeuw, C; Figeac, M; Gosset, P; Grandjean, T; Guery, B; Kipnis, E; Le Guern, R | 1 |
| Dong, J; Du, W; Han, W | 1 |
| Burrello, C; Caprioli, F; Facciotti, F; Giuffrè, MR; Lattanzi, G; Pujolassos, M; Strati, F; Troisi, J | 1 |
| Cho, JY; Chung, JY; Ji, SC; Kim, AH; Kim, E; Lee, Y; Yu, KS | 1 |
| Biedermann, L | 1 |
| Chen, X; Wang, W; Zhu, Y | 1 |
| Amagai, M; Aoki, R; Fukuda, S; Hattori, M; Hayashi, A; Kamada, N; Kanai, T; Mikami, Y; Miyamoto, K; Mizuno, S; Naganuma, M; Ohyama, M; Sato, T; Suda, W; Teratani, T | 1 |
| Byrne, B; Cannon, K; Chesnel, L; Happe, J; Louie, T; Ward, L; Wu, K | 1 |
| Antignano, F; Cait, A; Cait, J; Dimitriu, PA; Finlay, BB; Hacker, L; Hughes, MR; Maas, KR; McNagny, KM; Mohn, WW; Mohr, J; Reynolds, LA; Zaph, C | 1 |
| Belkaid, Y; Brenchley, JM; Busman-Sahay, K; DiNapoli, SR; Estes, JD; Flynn, JK; Johnston, L; Lai, SH; Long, ME; Mudd, JC; Ortiz, AM; Sortino, O; Starke, CE; Vinton, CL; Vujkovic-Cvijin, I | 1 |
| Batista, R; Davido, B; Denis, M; Dinh, A; Escaut, L; Fessi, H; Lawrence, C; Michelon, H; Perronne, C; Salomon, J | 1 |
| Fukui, H; Miwa, H; Oshima, T; Ran, Y; Tomita, T; Watari, J; Xu, X | 1 |
| Li, R; Lu, D; Ran, Z; Tian, M; Yang, J; Yin, J; Zhang, Y; Zhong, J; Zhou, Y | 1 |
| Jiang, D; Jiang, Z; Lai, Y; Li, D; Peng, H; Ren, H; Wu, Y; Zhang, M | 1 |
| Gong, J; Gu, L; Guo, D; Li, J; Li, N; Wei, Y; Zhu, W | 1 |
4 trial(s) available for vancomycin and Disbacteriosis
| Article | Year |
|---|---|
Effects of vancomycin-induced gut microbiome alteration on the pharmacodynamics of metformin in healthy male subjects.
Topics: Adult; Diabetes Mellitus, Type 2; Drug Interactions; Dysbiosis; Enterobacter; Faecalibacterium; Feces; Firmicutes; Gastrointestinal Microbiome; Healthy Volunteers; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Vancomycin; Young Adult | 2021 |
Enteric microbiome profiles during a randomized Phase 2 clinical trial of surotomycin versus vancomycin for the treatment of Clostridium difficile infection.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Load; Bacteriological Techniques; Clostridium Infections; Double-Blind Method; Dysbiosis; Feces; Female; Gastrointestinal Microbiome; Humans; Lipopeptides; Male; Metagenomics; Middle Aged; Peptides, Cyclic; Real-Time Polymerase Chain Reaction; Time Factors; Vancomycin; Young Adult | 2017 |
Fecal microbiota transplantation to eradicate vancomycin-resistant enterococci colonization in case of an outbreak.
Topics: Aged; Aged, 80 and over; Antibiosis; Clostridium Infections; Disease Eradication; Disease Outbreaks; Dysbiosis; Fecal Microbiota Transplantation; Female; Follow-Up Studies; France; Gram-Positive Bacterial Infections; Humans; Intestines; Male; Middle Aged; Pilot Projects; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci | 2019 |
Fecal microbiota transplantation restores dysbiosis in patients with methicillin resistant Staphylococcus aureus enterocolitis.
Topics: Adult; Child; Combined Modality Therapy; Cross Infection; Dysbiosis; Enterocolitis; Fecal Microbiota Transplantation; Feces; Female; Gastrointestinal Microbiome; Humans; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Vancomycin; Young Adult | 2015 |
19 other study(ies) available for vancomycin and Disbacteriosis
| Article | Year |
|---|---|
Effects of Four Antibiotics on the Diversity of the Intestinal Microbiota.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria; Dysbiosis; Gastrointestinal Microbiome; Humans; Metronidazole; Mice; Neomycin; RNA, Ribosomal, 16S; Vancomycin | 2022 |
Saireito, a Japanese herbal medicine, alleviates leaky gut associated with antibiotic-induced dysbiosis in mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Colitis; Colitis, Ulcerative; Disease Models, Animal; Drugs, Chinese Herbal; Dysbiosis; Herbal Medicine; Inflammation; Intestinal Mucosa; Japan; Mice; Mice, Inbred C57BL; Vancomycin | 2022 |
Experimental bacterial dysbiosis with consequent immune alterations increase intrarectal SIV acquisition susceptibility.
Topics: Animals; Anti-Bacterial Agents; Dysbiosis; Macaca mulatta; Simian Immunodeficiency Virus; Vancomycin | 2023 |
Vancomycin-induced gut microbial dysbiosis alters enteric neuron-macrophage interactions during a critical period of postnatal development.
Topics: Animals; Anti-Bacterial Agents; Dysbiosis; Gastrointestinal Microbiome; Macrophages; Mice; Neurons; Sepsis; Vancomycin | 2023 |
Vancomycin-induced gut dysbiosis during Pseudomonas aeruginosa pulmonary infection in a mice model.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Dysbiosis; Feces; Gastrointestinal Microbiome; Intestines; Lung; Mice; Mice, Inbred C57BL; Pseudomonas aeruginosa; Pseudomonas Infections; Vancomycin | 2020 |
Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota.
Topics: Animals; Bacteria; Bile Acids and Salts; Dietary Fiber; Dietary Supplements; Dysbiosis; Fatty Acids, Volatile; Fermentation; Gastrointestinal Microbiome; Inulin; Liver Neoplasms; Mice; Mice, Knockout; Toll-Like Receptor 5; Vancomycin | 2020 |
Antibiotic-induced dysbiosis of the rat oral and gut microbiota and resistance to Salmonella.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Disease Resistance; Dysbiosis; Gastrointestinal Microbiome; Mouth; Rats; RNA, Ribosomal, 16S; Salmonella Infections, Animal; Salmonella typhimurium; Vancomycin | 2020 |
Vancomycin exposure caused opportunistic pathogens bloom in intestinal microbiome by simulator of the human intestinal microbial ecosystem (SHIME).
Topics: Dysbiosis; Ecosystem; Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Humans; Vancomycin | 2020 |
Antibiotic-related gut dysbiosis induces lung immunodepression and worsens lung infection in mice.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Dysbiosis; Immunosuppression Therapy; Lung; Mice, Inbred C57BL; Microbiota; Pneumonia; Pseudomonas aeruginosa; Vancomycin | 2020 |
Long-term oral vancomycin for refractory inflammatory bowel diseases without Clostridium difficile infection: Lessons from primary sclerosing cholangitis.
Topics: Cholangitis, Sclerosing; Clostridium Infections; Dysbiosis; Humans; Inflammatory Bowel Diseases; Vancomycin | 2020 |
Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models.
Topics: Animals; Anti-Bacterial Agents; Colitis; Disease Models, Animal; Dysbiosis; Fecal Microbiota Transplantation; Female; Gastrointestinal Microbiome; Humans; Male; Metronidazole; Mice; Natural Killer T-Cells; Streptomycin; Th1 Cells; Th17 Cells; Vancomycin | 2021 |
Vancomycin in Very-Early Onset Inflammatory Bowel Disease-Dysbiosis: Fight Fire with Fire?
Topics: Age Factors; Anti-Bacterial Agents; Dysbiosis; Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Humans; Inflammatory Bowel Diseases; Treatment Outcome; Vancomycin | 2017 |
Selective Imaging of Gram-Negative and Gram-Positive Microbiotas in the Mouse Gut.
Topics: Animals; Azides; Carbocyanines; Cell Wall; Click Chemistry; Diagnostic Techniques, Digestive System; Dysbiosis; Fluorescent Dyes; Gastrointestinal Microbiome; Gastrointestinal Tract; Gram-Negative Bacteria; Gram-Positive Bacteria; Lipopolysaccharides; Mice, Inbred C57BL; Microbial Viability; Optical Imaging; Pilot Projects; Porphobilinogen; Rhodamines; Specific Pathogen-Free Organisms; Sugar Acids; Vancomycin | 2017 |
Intestinal Dysbiosis and Biotin Deprivation Induce Alopecia through Overgrowth of Lactobacillus murinus in Mice.
Topics: Alopecia; Animals; Anti-Bacterial Agents; Biotin; Diet; Dysbiosis; Gastrointestinal Microbiome; Intestinal Mucosa; Lactobacillus; Male; Metagenome; Mice; RNA, Ribosomal, 16S; Skin; Vancomycin | 2017 |
Microbiome-driven allergic lung inflammation is ameliorated by short-chain fatty acids.
Topics: Allergens; Animals; Antigen Presentation; Asthma; Chemokine CCL19; Dendritic Cells; Dietary Supplements; Dysbiosis; Fatty Acids, Volatile; Gastrointestinal Microbiome; Hypersensitivity; Interleukin-4; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Microbiota; Pneumonia; Th2 Cells; Vancomycin | 2018 |
Experimental microbial dysbiosis does not promote disease progression in SIV-infected macaques.
Topics: Animals; Disease Progression; Dysbiosis; Macaca mulatta; Male; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Vancomycin | 2018 |
Alteration of GLP-1/GPR43 expression and gastrointestinal motility in dysbiotic mice treated with vancomycin.
Topics: Animals; Body Weight; Dysbiosis; Female; Gastrointestinal Microbiome; Gastrointestinal Motility; Gastrointestinal Tract; Glucagon-Like Peptide 1; Mice; Receptors, G-Protein-Coupled; Vancomycin | 2019 |
Commensal Microbes Affect Host Humoral Immunity to
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Bacteroidetes; Bordetella pertussis; Dysbiosis; Female; Firmicutes; Gastrointestinal Microbiome; Immunity, Humoral; Immunity, Innate; Immunoglobulin G; Metronidazole; Mice; Mice, Inbred BALB C; Neomycin; Proteobacteria; Symbiosis; Vancomycin; Whooping Cough | 2019 |
Oral antibiotic treatment induces skin microbiota dysbiosis and influences wound healing.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacterial Load; Computational Biology; Down-Regulation; Dysbiosis; Interleukin-17; Male; Mice; Mice, Inbred C57BL; Microbiota; Pancreatitis-Associated Proteins; Proteins; RNA, Bacterial; RNA, Ribosomal, 16S; Skin; Staphylococcus; Vancomycin; Wound Healing | 2015 |